| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/07/2004 | EP1377577A1 Pyrrole derivates for treating cytokine mediated diseases |
| 01/07/2004 | EP1377576A2 Pyridine derivatives |
| 01/07/2004 | EP1377575A1 Antiviral pyrazolopyridine compounds |
| 01/07/2004 | EP1377574A1 6-phenylbenzonaphthyridines |
| 01/07/2004 | EP1377573A2 Pyrazolopyridine derivatives |
| 01/07/2004 | EP1377567A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 01/07/2004 | EP1377556A1 Pyrazole derivatives for treating hiv |
| 01/07/2004 | EP1377555A1 Novel compounds |
| 01/07/2004 | EP1377552A1 Metal complexes and therapeutic uses thereof |
| 01/07/2004 | EP1377293A1 Aryl and biaryl piperidines used as mch antagonists |
| 01/07/2004 | CN1466586A Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 01/07/2004 | CN1466577A 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 01/07/2004 | CN1466572A 吡咯衍生物 Azole derivatives |
| 01/07/2004 | CN1133634C Heterocyclic derivatives which inhibit factor Xa |
| 01/06/2004 | US6673929 Process for preparing growth hormone secretagogues |
| 01/06/2004 | US6673928 Metalating an indolizine not having a substituent at the 5-position with a metal compound and, reacting with a boric acid ester compund to form the end porduct |
| 01/06/2004 | US6673812 Administering effective amount of compound having rho kinase inhibitory activity |
| 01/06/2004 | US6673811 Treatment of anxiety, depression, sleep disorder, attention deficit disorder, alzheimer's dementia, or short-term memory loss |
| 01/06/2004 | US6673810 Anticoagulants |
| 01/06/2004 | US6673804 Preventing or treating arthritis (particularly osteoarthritis) or inhibiting metastasis, invasion or growth of cancer (particularly breast cancer) |
| 01/06/2004 | US6673797 Cyclooxygenase-2 inhibitors; treating inflammatory disease induced by cyclooxygenase-2 |
| 01/06/2004 | US6673791 Non-nucleoside reverse transcriptase inhibitors |
| 01/06/2004 | US6673781 Inhibit secretory phospholipase a2-mediated fatty acid release; treating adult respiratory syndrome, pancreatitis, bronchial asthma, allergic rhinitis, chronic rheumatism, arteriosclerosis, cerebral infarction and psoriasis |
| 01/06/2004 | US6673557 Methods of treatment of eye trauma and disorders |
| 01/06/2004 | CA2301990C New substitute dimerized derivatives, process for preparing them, and pharmaceutical compounds containing them |
| 01/02/2004 | EP1375624A1 Device containing green organic light-emitting diode |
| 01/02/2004 | EP1375501A1 Process for enantiomeric enrichment of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo(4.3.0)nonane using simulated moving bed chromatography |
| 01/02/2004 | EP1375496A1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient |
| 01/02/2004 | EP1375486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 01/02/2004 | EP1375482A1 Benzamidine derivative |
| 01/02/2004 | EP1374897A1 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates |
| 01/02/2004 | EP1373272A2 Tert. alkylphenoxy substituted polycyclic compounds |
| 01/02/2004 | EP1373271A1 Indole derivatives having an inhibitory effect on protein kinases |
| 01/02/2004 | EP1373269A1 Jun kinase inhibitors |
| 01/02/2004 | EP1373267A2 Non-nucleoside reverse transcriptase inhibitors |
| 01/02/2004 | EP1373266A2 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 01/02/2004 | EP1373259A1 Pyridazinone aldose reductase inhibitors |
| 01/02/2004 | EP1373250A1 Viologen linked acridine based molecule and process for the preparation thereof |
| 01/02/2004 | EP1373247A2 Spiroisoquinoline compounds, methods for their preparation and intermediates thereof |
| 01/02/2004 | EP1373240A2 Retinoid x receptor modulators |
| 01/02/2004 | EP1373222A2 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1372648A2 Tie2 receptor kinase inhibitors for treating angiogenic diseases |
| 01/02/2004 | EP1372647A2 Use of substituted imidazo 1,2-a]-pyridine compounds as medicaments |
| 01/02/2004 | EP1372644A2 Use of substituted imidazo 1,2-a]-pyridine-3-yl-amide and imidazo 1,2-a]-pyridine-3-yl-amine compounds as medicaments |
| 01/02/2004 | EP1372643A1 Pyrazolopyridines, process for their preparation and use as therapeutic compounds |
| 01/02/2004 | EP1372642A1 Use of pyrazolopyridines as therapeutic compounds |
| 01/01/2004 | US20040002605 Reacting 1,4-dialkylcarboxylate-2,5-bis(N-arylamino)benzene with iodoaryl compound |
| 01/01/2004 | US20040002604 Phenylalkynes |
| 01/01/2004 | US20040002603 Method for making nevirapine |
| 01/01/2004 | US20040002602 Synthetic process for the manufacture of an ecteinaschidin compound |
| 01/01/2004 | US20040002518 Anticancer agents; tyrosine kinase inhibitor; wound healing agents |
| 01/01/2004 | US20040002515 Antihistamines; antiallergens; antiinflammatory agents; autoimmune diseases; rheumatic diseases |
| 01/01/2004 | US20040002513 3-Substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 01/01/2004 | US20040002512 Alpha-substituted carboxylic acid derivatives |
| 01/01/2004 | US20040002511 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators |
| 01/01/2004 | US20040002508 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 01/01/2004 | US20040002498 Tricyclic compounds useful as HIV reverse transcriptase inhibitors |
| 01/01/2004 | US20040002496 Compositions useful as inhibitors of protein kinases |
| 01/01/2004 | US20040002495 Lactam glycogen phosphorylase inhibitors and method of use |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |
| 01/01/2004 | US20040002489 Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors |
| 01/01/2004 | US20040002488 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| 01/01/2004 | US20040002487 Bone disorders; osteoporosis; oral diseases; antiarthritic agents |
| 01/01/2004 | US20040002424 2-Amino-4-bicyclylamino-6H-1,3,5-triazines, processes for their preparation and their use as herbicides and plant growth regulators |
| 01/01/2004 | US20040001971 Blue light-emitting compound for organic electroluminescent device and organic electroluminescent device using the same |
| 01/01/2004 | US20040001970 Organic electroluminescent materials and devices made from such materials |
| 01/01/2004 | US20040001969 Device containing green organic light-emitting diode |
| 12/31/2003 | WO2004000856A1 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd |
| 12/31/2003 | WO2004000842A1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
| 12/31/2003 | WO2004000841A1 Hetero-bicyclic compounds |
| 12/31/2003 | WO2004000832A1 1-[(indol-3-yl)carbonyl] piperazine derivatives |
| 12/31/2003 | WO2004000831A1 Indole derivatives useful as histamine h3 antagonists |
| 12/31/2003 | WO2004000828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| 12/31/2003 | WO2004000814A1 8-(biaryl) quinoline pde4 inhibitors |
| 12/31/2003 | WO2004000804A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
| 12/31/2003 | WO2004000800A2 Electrochromic salts, solutions, and devices |
| 12/31/2003 | WO2004000210A2 Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
| 12/31/2003 | WO2004000205A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 12/31/2003 | WO2003069303A3 Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof |
| 12/31/2003 | WO2003066586A3 Purine and isosteric antibacterial compounds |
| 12/31/2003 | WO2003059269A3 Acridone inhibitors of impdh enzyme |
| 12/31/2003 | WO2001006984A3 Small molecules useful in the treatment of inflammatory disease |
| 12/31/2003 | CN1464878A Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors |
| 12/31/2003 | CN1463973A Novel anticancer plants extract, process of extraction and analogue thereof |
| 12/31/2003 | CN1132837C 螺呋喃并吡啶芳烷基胺、其制法和中间体及其药物组合物和制药用途 Spiro furopyridine arylalkylamines, their preparation and intermediates and pharmaceutical compositions thereof and pharmaceutical use |
| 12/31/2003 | CN1132836C 各种片螺素化合物和类似物的合成及中间体 And various synthetic intermediates lamellarin compounds and the like |
| 12/31/2003 | CN1132835C Process for preparing alooerine |
| 12/31/2003 | CN1132834C Process for preparing matrine from sophocarpine by transhydrogenation |
| 12/31/2003 | CN1132819C 作为TNF－α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors |
| 12/31/2003 | CA2490526A1 Hetero-bicyclic compounds |
| 12/31/2003 | CA2490109A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
| 12/31/2003 | CA2490043A1 8-(biaryl) quinoline pde4 inhibitors |
| 12/31/2003 | CA2486989A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| 12/31/2003 | CA2445515A1 Transcription factor modulating compounds and methods of use thereof |
| 12/30/2003 | US6670479 Amination process |
| 12/30/2003 | US6670476 Reacting racemic mixture of said compound with naproxen forming salts; for treating disorders of the dopamine system |
| 12/30/2003 | US6670456 Actinium-225 complexes and conjugates for targeted radiotherapy |
| 12/30/2003 | US6670447 Amino acid N-carboxyanhydrides with acyl substituents on nitrogen atoms thereof |